Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilanterol dose-ranging in pediatric asthma
NCT01573767Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of vilanterol in asthma, sponsored by GSK. Started Apr 2012; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01573767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573767.